🇺🇸 FDA
Patent

US 9730941

Methods and compositions for the inhibition of Pin1

granted A61KA61K31/185A61K31/341

Quick answer

US patent 9730941 (Methods and compositions for the inhibition of Pin1) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 15 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 10 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/185, A61K31/341, A61K31/357, A61K31/365